U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.
Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech
...
Read moreDetails

